|
1
|
Pennathur A, Gibson MK, Jobe BA and
Luketich JD: Oesophageal carcinoma. Lancet. 381:400–412. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wen SW, Zhang YF, Li Y, Liu ZX, Lv HL, Li
ZH, Xu YZ, Zhu YG and Tian ZQ: Characterization and effects of
miR-21 expression in esophageal cancer. Genet Mol Res.
14:8810–8818. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen W, He Y, Zheng R, Zhang S, Zeng H,
Zou X and He J: Esophageal cancer incidence and mortality in China,
2009. J Thorac Dis. 5:19–26. 2013.PubMed/NCBI
|
|
4
|
Peng JZ, Xue L, Liu DG and Lin YH:
Association of the p53 Arg72Pro polymorphism with esophageal cancer
in Chinese populations: A meta-analysis. Genet Mol Res.
14:9024–9033. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Garzon R and Croce CM: MicroRNAs and
cancer: Introduction. Semin Oncol. 38:721–723. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mulrane L, Klinger R, McGee SF, Gallagher
WM and O'Connor DP: microRNAs: A new class of breast cancer
biomarkers. Expert Rev Mol Diagn. 14:347–363. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ma J and Li X: MicroRNAs are involved in
the toxicity of microcystins. Toxin Rev. 36:165–175. 2017.
View Article : Google Scholar
|
|
9
|
Fu H, Tie Y, Xu C, Zhang Z, Zhu J, Shi Y,
Jiang H, Sun Z and Zheng X: Identification of human fetal liver
miRNAs by a novel method. FEBS Lett. 579:3849–3854. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
De-Ugarte L, Yoskovitz G, Balcells S,
Güerri-Fernández R, Martinez-Diaz S, Mellibovsky L, Urreizti R,
Nogués X, Grinberg D, García-Giralt N and Díez-Pérez A: miRNA
profiling of whole trabecular bone: Identification of
osteoporosis-related changes in miRNAs in human hip bones. BMC Med
Genomics. 8:752015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Veronese A, Lupini L, Consiglio J, Visone
R, Ferracin M, Fornari F, Zanesi N, Alder H, D'Elia G, Gramantieri
L, et al: Oncogenic role of miR-483-3p at the IGF2/483 locus.
Cancer Res. 70:3140–3149. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang C, Sun Y, Wu H, Zhao D and Chen J:
Distinguishing adrenal corticalcarcinomas and adenomas: A study of
clinicopathological features and biomarkers. Histopathology.
64:567–576. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li HY, Liu YC, Bai YH, Sun M, Wang L,
Zhang XB and Cai B: SNP at miR-483-5p-binding site in the
3′-untranslated region of the BSG gene is associated with
susceptibility to esophageal cancer in a Chinese population. Genet
Mol Res. 15:1–10. 2016.
|
|
14
|
Baba Y, Watanabe M and Baba H: A review of
the alterations in DNA methylation in esophageal squamous cell
carcinoma. Surgery today. 43:1355–1364. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Toh Y, NEgashira A and Yamamoto M:
Epigenetic alterations and their clinical implications in
esophageal squamous cell carcinoma. Gen Thorac Cardiovasc Surg.
61:262–269. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang K, Johnson A, Ali SM, Klempner SJ,
Bekaii-Saab T, Vacirca JL, Khaira D, Yelensky R, Chmielecki J,
Elvin JA, et al: Comprehensive genomic profiling of advanced
esophageal squamous cell carcinomas and esophageal adenocarcinomas
reveals similarities and differences. Oncologist. 20:1132–1139.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Olson P, Lu J, Zhang H, Shai A, Chun MG,
Wang Y, Libutti SK, Nakakura EK, Golub TR and Hanahan D: MicroRNA
dynamics in the stages of tumorigenesis correlate with hallmark
capabilities of cancer. Genes Dev. 23:2152–2165. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Soon PS, Tacon LJ, Gill AJ, Bambach CP,
Sywak MS, Campbell PR, Yeh MW, Wong SG, Clifton-Bligh RJ, Robinson
BG and Sidhu SB: miR-195 and miR-483-5p identified as predictors of
poor prognosis in adrenocortical cancer. Clin Cancer Res.
15:7684–7692. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li F, Ma N, Zhao R, Wu G, Zhang Y, Qiao Y,
Han D, Xu Y, Xiang Y, Yan B, et al: Overexpression of miR-483-5p/3p
cooperate to inhibit mouse liver fibrosis by suppressing the TGF-β
stimulated HSCs in transgenic mice. Cell Mol Med. 18:966–974. 2014.
View Article : Google Scholar
|
|
21
|
Ma N, Wang X, Qiao Y, Li F, Hui Y, Zou C,
Jin J, Lv G, Peng Y, Wang L, et al: Coexpression of an intronic
microRNA and its host gene reveals a potential role for miR-483-5p
as an IGF2 partner. Mol Cell Endocrinol. 333:96–101. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Srinivasan S, Selvan ST, Archunan G,
Gulyas B and Padmanabhan P: MicroRNAs-the next generation
therapeutic targets in human diseases. Theranostics. 3:930–942.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Song Q, Xu Y, Yang C, Chen Z, Jia C, Chen
J, Zhang Y, Lai P, Fan X, Zhou X, et al: miR-483-5p promotes
invasion and metastasis of lung adenocarcinoma by targeting RhoGDI1
and ALCAM. Cancer Res. 74:3031–3042. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tovar V, Alsinet C, Villanueva A, Hoshida
Y, Chiang DY, Solé M, Thung S, Moyano S, Toffanin S, Mínguez B, et
al: IGF activation in a molecular subclass of hepatocellular
carcinoma and pre-clinical efficacy of IGF-1R blockage. Hepatol.
52:550–559. 2010. View Article : Google Scholar
|
|
25
|
Verma A, Shukla NK, Deo SV, Gupta SD and
Ralhan R: MEMD/ALCAM: A potential marker for tumor invasion and
nodal metastasis in esophageal squamous cell carcinoma. Oncology.
68:462–470. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Eskandari L, Akbarzadeh A, Zarghami N and
Rahmati-Yamchi M: Gold nanoprobe-based method for sensing activated
leukocyte cell adhesion molecule (ALCAM) gene expression, as a
breast cancer biomarker. Artif Cells Nanomed Biotechnol.
45:277–282. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hui B, Chen X, Hui L, Xi R and Zhang X:
Serum miRNA expression in patients with esophageal squamous cell
carcinoma. Oncol Lett. 10:3008–3012. 2015.PubMed/NCBI
|
|
28
|
Shi L, Liu S, Zhao W and Shi J: miR-483-5p
and miR-486-5p are down-regulated in cumulus cells of metaphase II
oocytes from women with polycystic ovary syndrome. Reprod Biomed
Online. 31:565–572. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jorgensen SB, O'Neill HM, Sylow L,
Honeyman J, Hewitt KA, Palanivel R, Fullerton MD, Öberg L,
Balendran A and Galic S: Deletion of skeletal muscle SOCS3 prevents
insulin resistance in obesity. Diabetes. 62:56–64. 2013. View Article : Google Scholar : PubMed/NCBI
|
